Natesan Murugesan
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Nitric Oxide and Endothelin Effects, Renin-Angiotensin System Studies, Receptor Mechanisms and Signaling, Chemical synthesis and alkaloids, Metal complexes synthesis and properties
Most-Cited Works
- → The Discovery of Sulfonamide Endothelin Antagonists and the Development of the Orally Active ETA Antagonist 5-(Dimethylamino)-N-(3,4-dimethyl-5- isoxazolyl)-1-naphthalenesulfonamide(1994)137 cited
- → Bleomycin as an oxene transferase. Catalytic oxygen transfer to olefins(1985)89 cited
- → Dual Angiotensin II and Endothelin A Receptor Antagonists: Synthesis of 2‘-Substituted N-3-Isoxazolyl Biphenylsulfonamides with Improved Potency and Pharmacokinetics(2004)86 cited
- → Chemistry of the alkali-labile lesion formed from iron(II) bleomycin and d(CGCTTTAAAGCG)(1988)83 cited
- → Analysis of products formed during bleomycin-mediated DNA degradation(1985)72 cited
- → Structure of the alkali-labile product formed during iron(II)-bleomycin-mediated DNA strand scission(1985)70 cited
- → The chemistry of vicinal tricarbonyls. A stable vinyl tricarbonyl hydrate as a di- and trielectrophile(1989)64 cited
- → Biphenylsulfonamide Endothelin Receptor Antagonists. 4. Discovery of N-[[2‘-[[(4,5-Dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1‘-biphenyl]- 2-yl]methyl]-N,3,3-trimethylbutanamide (BMS-207940), A Highly Potent and Orally Active ETA Selective Antagonist(2002)62 cited
- → Activation of oxygen and mediation of DNA degradation by manganese-bleomycin(1984)62 cited
- → Discovery of N-Isoxazolyl Biphenylsulfonamides as Potent Dual Angiotensin II and Endothelin A Receptor Antagonists(2002)53 cited